Latest Strategy Changes News

Orezone Gold has outlined a 14-year plan for its newly acquired Casa Berardi mine, targeting 1.63 million ounces of production and an after-tax NPV of US$1.05 billion. The economics are substantial, but the plan remains a preliminary assessment built partly on Inferred Resources and requires significant capital and permitting work.

True North Copper has lifted the contained copper inventory across its Cloncurry Copper Project by approximately 18% through a larger Mongoose-Taipan resource. The update gives the late-2026 pre-feasibility study a bigger technical base, but it remains a mineral resource rather than an economic reserve.

Paragon Care has lined up an on-market buy-back of up to 82.8 million shares, worth about $10.8 million at the latest closing price, while its employee trust can acquire a further 23.9 million shares. The transactions give the healthcare group two sizeable tools for managing its capital and incentive plans, although neither maximum is guaranteed to be completed.

Pantoro Gold has extended the interpreted mineralised strike at its Racetrack discovery to about 900 metres, with drilling returning several high-grade intersections. The company will begin a 450-metre exploration decline from the OK Underground Mine in the December 2026 quarter, although Racetrack remains outside the current Mineral Resource and Ore Reserve.

Vicinity Centres has positioned portfolio premiumisation and development execution as the engine of future growth, but its Chadstone case study also shows how quickly valuation assumptions can alter project returns. The company highlighted a potential residential expansion at Chatswood Chase alongside strong occupancy, modest gearing and a large development pipeline.

Medibank delivered higher FY26 operating profit, underlying earnings and dividends, while its health services arm posted strong growth after the Better Medical acquisition. The annual report also leaves investors weighing cybercrime litigation, capital flexibility and the pace of Medibank Health’s expansion.

Cazaly Resources will replace managing director Tara French with mining executive Adrian Byass from 8 October, while launching a review of its exploration portfolio. Byass will receive a $325,000 annual salary and may be granted up to 7 million performance rights, subject to approval and conditions.

James Hardie has raised its FY27 Free Cash Flow target to at least US$600 million and expects to deliver its US$125 million cost synergy target roughly a year early. The company also outlined a 4% to 7% annual organic growth ambition above market, while targeting net leverage below 2.0x by Q2 FY28.

Auric Mining has acquired second-hand crushing and processing infrastructure for $1.2 million, securing key equipment for its planned Burbanks restart at a substantial discount to estimated replacement cost. The package is scheduled to move from New South Wales in late 2026, with installation preparation targeted for early 2027.

American Tungsten & Antimony has started an ahead-of-schedule campaign to produce antimony flake at its Del Sol refinery in Nevada, using material from Arizona. The first physical demonstration of its proposed US mine-to-metal chain could generate samples for customer qualification and government discussions, although the underlying asset acquisition remains incomplete.

Elixir Energy says its Lorelle-3H well reached a peak test rate of 10.5 MMscfd and a stable rate of 2.35 MMscfd during first-phase cleanup. The ASX-listed gas explorer is now preparing for post-soak testing while weighing farm-outs, joint ventures and other structures for its Taroom Trough assets.

Industrial Minerals has completed its shift from an industrial-minerals explorer towards Western Australia gold, adding a 205 square kilometre Laverton portfolio after year end. The company enters the next phase with historical high-grade intercepts, a planned maiden drilling campaign and $2.08 million in cash at 30 June.